Mona Saraiya, MD, MPH
Mona Saraiya, MD, MPH, is a Medical Officer and Team Lead in CDC’s Division of Cancer Prevention and Control’s (DCPC’s) Epidemiology and Applied Research Branch. Prior to her current position, Dr. Saraiya was Associate Director of DCPC’s Office of International Cancer Control. She has also worked on domestic issues related to skin cancer epidemiology and cervical cancer prevention and control. Her cervical cancer and human papillomavirus (HPV) research portfolio includes an initiative to characterize the HPV-associated cancer burden in the United States, and adherence to cervical cancer screening guidelines, especially with newer technologies such as HPV testing.
She graduated from Rush Medical College, completed a Masters of Public Health at Emory School of Public Health, completed a residency in Preventive Medicine/Public Health, and is board certified by the American College of Preventive Medicine.
Dr. Saraiya is an alumna of the Epidemic Intelligence Service program and has published more than 150 articles during her tenure at CDC.
Some of the most recent articles Dr. Saraiya has authored include—
- 2020 Risk of cervical precancer and cancer among uninsured and underserved women 2009–2017.external icon
- 2020 Is India’s public health care system prepared for cervical cancer screening?: Evaluating facility readiness from the fourth round of the District Level Household and Facility Survey (DLHS-4).external icon
- 2020 Cancer mortality in the US-Affiliated Pacific Islands, 2008–2013.external icon
- 2020 Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.external icon
- 2019 Cervical cancer death rates among U.S.- and foreign-born women: U.S., 2005–2014.external icon
- 2019 Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population.external icon
- 2019 Gastric cancer mortality rates among US and foreign-born persons: United States 2005–2014.external icon
- 2019 Establishing baseline cervical cancer screening coverage—India, 2015–2016.
- 2019 Trends in liver cancer mortality in the United States: Dual burden among foreign- and US-born persons.external icon
- 2018 Trends in human papillomavirus-associated cancer—United States, 1999–2015.
- 2018 Preventing global human papillomavirus-associated lower genital disease.external icon
- 2018 Population-based assessment of HPV genotype-specific cervical cancer survival: CDC Cancer Registry Sentinel Surveillance System.external icon
- 2018 CDC activities to enhance training in cancer prevention and control in field epidemiology training programs in low- and middle-income countries.external icon
- 2018 Cervical cancer screening among women by birthplace and percent of lifetime living in the United States.external icon
- 2018 Cervical cancer screening intervals preferred by U.S. women.external icon
- 2018 Racial disparities in fifth-grade sun protection: Evidence from the Healthy Passages study.external icon
- 2018 Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.external icon
- 2018 Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.external icon
- 2017 Primary HPV testing: U.S. women’s awareness and acceptance of an emerging screening modality.external icon
- 2016 Importance of economic evaluation of cancer registration in the resource limited setting: Laying the groundwork for surveillance systems.external icon
- 2015 U.S. assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.external icon
- 2015 A door-to-door approach to cervical cancer screening.external icon
- 2015 Evidence is lacking to support pelvic examinations as a screening tool for non-cervical cancers or other conditions.external icon
- 2014 Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.external icon
- 2014 A need for improved understanding about USPSTF and other evidence-based recommendations.external icon
- 2013 Evolution of cervical cancer screening and prevention in the United States and Canada.external icon
- 2012 Cancers that U.S. physicians believe the HPV vaccine prevents: Findings from a physician survey, 2009.external icon
- 2011 Cervical cancer screening among women who attend sexually transmitted disease (STD) clinics: background paper for 2010 STD treatment guidelines.external icon
- 2011 HPV vaccine effect: is the glass half full or half empty? [comment]external icon
- 2010 Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.external icon
- 2010 Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.external icon
- 2010 Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs. Papanicolaou testing alone: what screening intervals are physicians recommending?external icon
- 2010 Common abnormal results of Pap and human papillomavirus cotesting: what physicians are recommending for management.external icon
- 2009 Liquid-based cytology vs conventional cytology in detecting cervical cancer.external icon
- 2009 Pap testing and sexual activity among young women in the United States.external icon
- 2009 Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007.external icon
- 2008 Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role.external icon
- 2008 Incidence of in situ and invasive vulvar cancer in the U.S., 1998–2003.external icon
- 2008 Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the U.S.external icon
- 2007 Cervical cancer incidence in a prevaccine era in the United States, 1998–2002.external icon
- 2007 Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).external icon
- 2007 Sunburn prevalence among adults—United States, 1999, 2003, and 2004.
- 2005 Total and percent free prostate-specific antigen levels among U.S. men, 2001–2002.external icon
- 2004 Cervical cancer screening among women without a cervix.external icon
- 2004 Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review.external icon
- 2004 Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys.external icon
- 2003 Preventing skin cancer: Findings of the Task Force on Community Preventive Services on reducing exposure to ultraviolet light.
- 2002 Observations from the CDC: An assessment of Pap smears and hysterectomies among women in the United States.external icon
- 2002 Sunburn prevalence among adults in the United States, 1999.external icon
- 2001 Self-reported Papanicolaou smears and hysterectomies among women in the United States.external icon
- 2001 The role of family history in personal and clinical cancer prevention practices among U.S. women physicians.external icon
- 2000 Personal and clinical skin cancer prevention practices of U.S. women physicians.external icon
Dr. Saraiya is featured in the following videos—
Preventing Cervical Cancer in the 21st Century
In this session of Public Health Grand Rounds, Dr. Saraiya explains the epidemiology of cervical cancer.
Page last reviewed: July 14, 2020